Literature DB >> 15557322

UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells.

Marie-Ange Renault1, Sandra Jalvy, Mylène Potier, Isabelle Belloc, Elisabeth Genot, Lodewijk V Dekker, Claude Desgranges, Alain-Pierre Gadeau.   

Abstract

Osteopontin (OPN) is an important chemokinetic agent for several cell types. Our earlier studies have shown that its expression is essential for uridine triphosphate (UTP)-mediated migration of vascular smooth muscle cells. We demonstrated previously that the activation of an AP-1 binding site located 76 bp upstream of the transcription start in the rat OPN promoter is involved in the induction of OPN expression. In this work, using a luciferase promoter deletion assay, we identified a new region of the rat OPN promoter (-1837 to -1757) that is responsive to UTP. This region contains an NFkappaB site located at -1800 and an Ebox located at -1768. Supershift electrophoretic mobility shift assay and chromatin immunoprecipitation assays identified NFkappaB and USF-1/USF-2 as the DNA binding proteins induced by UTP, respectively, for these two sites. Using dominant negative mutants of IkappaB kinase and USF transcription factors, we confirmed that NFkappaB and USF-1/USF-2 are involved in the UTP-mediated expression of OPN. Using a pharmacological approach, we demonstrated that USF proteins are regulated by the extracellular signal-regulated kinase (ERK)1/2 pathway, just as the earlier discovered AP-1 complex, whereas NFkappaB is up-regulated through PKCdelta signals. Finally, our work suggests that the UTP-stimulated OPN expression involves a coordinate regulation of PKCdelta-NFkappaB, ERK1/2-USF, and ERK1/2/NAD(P)H oxidase AP-1 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557322     DOI: 10.1074/jbc.M411786200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Nicotine induces pro-inflammatory response in aortic vascular smooth muscle cells through a NFκB/osteopontin amplification loop-dependent pathway.

Authors:  Yongyi Wang; Fei Zhang; Wengang Yang; Song Xue
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.

Authors:  Ermira Pazolli; Elise Alspach; Agnieszka Milczarek; Julie Prior; David Piwnica-Worms; Sheila A Stewart
Journal:  Cancer Res       Date:  2012-03-15       Impact factor: 12.701

3.  Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation.

Authors:  B Paul Herring; April M Hoggatt; Sarah L Griffith; Jeanette N McClintick; Patricia J Gallagher
Journal:  Physiol Genomics       Date:  2016-12-30       Impact factor: 3.107

4.  Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.

Authors:  Lisa M Nilsson-Berglund; Anna V Zetterqvist; Jenny Nilsson-Ohman; Mikael Sigvardsson; Laura V González Bosc; Maj-Lis Smith; Albert Salehi; Elisabet Agardh; Gunilla Nordin Fredrikson; Carl-David Agardh; Jan Nilsson; Brian R Wamhoff; Anna Hultgårdh-Nilsson; Maria F Gomez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

5.  Association analysis of allelic variants of USF1 in coronary atherosclerosis.

Authors:  Kati Kristiansson; Erkki Ilveskoski; Terho Lehtimäki; Leena Peltonen; Markus Perola; Pekka J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

6.  Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes.

Authors:  Ting-Chi Lu; Zhaohui Wang; Xiaobei Feng; Peter Chuang; Wei Fang; Yibang Chen; Susana Neves; Avi Maayan; Huabao Xiong; Yusen Liu; Ravi Iyengar; Paul E Klotman; John Cijiang He
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

7.  Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.

Authors:  Jung Yeon Kim; Byung-Noe Bae; Kyoung Soo Kim; Eunah Shin; Kyeongmee Park
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

8.  The role of ERK signaling in protein hydrogel remodeling by vascular smooth muscle cells.

Authors:  Helen Hong; Caitlyn M McCullough; Jan P Stegemann
Journal:  Biomaterials       Date:  2007-05-21       Impact factor: 12.479

9.  Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling.

Authors:  Xin Jin; Guo-xiang Fu; Xiao-dong Li; Ding-liang Zhu; Ping-jin Gao
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

10.  Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.

Authors:  Rajeev S Samant; David W Clark; Rebecca A Fillmore; Muzaffer Cicek; Brandon J Metge; Kondethimmana H Chandramouli; Ann F Chambers; Graham Casey; Danny R Welch; Lalita A Shevde
Journal:  Mol Cancer       Date:  2007-01-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.